Drug Description in Trials / DrugBank / KEGG DRUG
Search results
Showing 1 to 2 of 2 drugs
| No. | KEGG DRUG | DrugBank | 薬物名（臨床試験情報から抽出） | KEGG GENES | KEGG PATHWAY | 指定難病告示番号 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
Acalabrutinib
1. Acalabrutinib
(Acalabrutinib (JAN/USAN/INN)) | 1件: Acalabrutinib Acalabrutinib (Acalabrutinibum) | 1件: Acalabrutinib Acalabrutinib | 1件: BTK BTK 💬1. Acalabrutinib
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 2件: 46 46, 61 💬
| ||||||||
| 2 |
Acalabrutinib maleate hydrate
2. Acalabrutinib maleate hydrate
(Acalabrutinib maleate hydrate (JAN), Acalabrutinib maleate monohydrate) | 1件: Acalabrutinib Acalabrutinib (Acalabrutinibum) | 1件: Acalabrutinib Acalabrutinib | 1件: BTK BTK 💬2. Acalabrutinib maleate hydrate
| 7件: B cell receptor signaling pathway B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Platelet activation, Primary immunodeficiency 💬 7件: B cell receptor signaling pathway, Epstein-Barr virus infection, Fc epsilon RI signaling pathway ... | 2件: 46 46, 61 💬
|